Gefitinib NSCLC maintenance therapy

Por Cohen, Martin H.
Publicado no Transl Lung Cancer Res (2012)

Immunological studies in tropical splenomegaly syndrome in Uganda

Por Ziegler, John L., Cohen, Martin H., Hutt, M. S. R.
Publicado em 1969

FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma

Por Summers, Jeff, Cohen, Martin H., Keegan, Patricia, Pazdur, Richard
Publicado em 2010

Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Por Cohen, Martin H., Cortazar, Patricia, Justice, Robert, Pazdur, Richard
Publicado em 2010

Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors

Por Cohen, Martin H., Cortazar, Patricia, Justice, Robert, Pazdur, Richard
Publicado em 2010

Approval Summary: Letrozole (Femara® Tablets) for Adjuvant and Extended Adjuvant Postmenopausal Breast Cancer Treatment: Conversion of Accelerated to Full Approval

Por Cohen, Martin H., Johnson, John R., Justice, Robert, Pazdur, Richard
Publicado em 2011

Approval Summary: Imatinib Mesylate for One or Three Years in the Adjuvant Treatment of Gastrointestinal Stromal Tumors

Por Cohen, Martin H., Johnson, John R., Justice, Robert, Pazdur, Richard
Publicado em 2012

FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme

Por Cohen, Martin H., Shen, Yuan Li, Keegan, Patricia, Pazdur, Richard
Publicado em 2012

Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

Por Cohen, Martin H., Johnson, John R., Chattopadhyay, Somesh, Tang, Shenghui, Justice, Robert, Sridhara, Rajeshwari, Pazdur, Richard
Publicado em 2010

Approval Summary: Cetuximab in Combination With Cisplatin or Carboplatin and 5-Fluorouracil for the First-Line Treatment of Patients With Recurrent Locoregional or Metastatic Squam...

Por Cohen, Martin H., Chen, Huanyu, Shord, Stacy, Fuchs, Chana, He, Kun, Zhao, Hong, Sickafuse, Sharon, Keegan, Patricia, Pazdur, Richard
Publicado em 2013

U.S. Food and Drug Administration Approval: Peginterferon-alfa-2b for the Adjuvant Treatment of Patients with Melanoma

Por Herndon, Thomas M., Demko, Suzanne G., Jiang, Xiaoping, He, Kun, Gootenberg, Joseph E., Cohen, Martin H., Keegan, Patricia, Pazdur, Richard
Publicado em 2012